Literature DB >> 19309692

Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy.

Elena Martoni1, Anna Urciuolo, Patrizia Sabatelli, Marina Fabris, Matteo Bovolenta, Marcella Neri, Paolo Grumati, Adele D'Amico, Marika Pane, Eugenio Mercuri, Enrico Bertini, Luciano Merlini, Paolo Bonaldo, Alessandra Ferlini, Francesca Gualandi.   

Abstract

Splicing mutations occurring outside the invariant GT and AG dinucleotides are frequent in disease genes and the definition of their pathogenic potential is often challenging. We have identified four patients affected by Ullrich congenital muscular dystrophy and carrying unusual mutations of COL6 genes affecting RNA splicing. In three cases the mutations occurred in the COL6A2 gene and consisted of nucleotide substitutions within the degenerated sequences flanking the canonical dinucleotides. In the fourth case, a genomic deletion occurred which removed the exon8-intron8 junction of the COL6A1 gene. These mutations induced variable splicing phenotypes, consisting of exon skipping, intron retention and cryptic splice site activation/usage. A quantitative RNA assay revealed a reduced level of transcription of the mutated in-frame mRNA originating from a COL6A2 point mutation at intronic position +3. At variance, the transcription level of the mutated in-frame mRNA originating from a genomic deletion which removed the splicing sequences of COL6A1 exon 8 was normal. These findings suggest a different transcriptional efficiency of a regulatory splicing mutation compared to a genomic deletion causing a splicing defect. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309692     DOI: 10.1002/humu.21022

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

2.  Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.

Authors:  Samya Chakravorty; Babi Ramesh Reddy Nallamilli; Satish Vasant Khadilkar; Madhu Bala Singla; Ashish Bhutada; Rashna Dastur; Pradnya Satish Gaitonde; Laura E Rufibach; Logan Gloster; Madhuri Hegde
Journal:  Front Neurol       Date:  2020-11-05       Impact factor: 4.086

3.  Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies.

Authors:  Matteo Bovolenta; Marcella Neri; Elena Martoni; Anna Urciuolo; Patrizia Sabatelli; Marina Fabris; Paolo Grumati; Eugenio Mercuri; Enrico Bertini; Luciano Merlini; Paolo Bonaldo; Alessandra Ferlini; Francesca Gualandi
Journal:  BMC Med Genet       Date:  2010-03-19       Impact factor: 2.103

4.  Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors:  Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal:  Genome Med       Date:  2010-04-07       Impact factor: 11.117

5.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

6.  Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies.

Authors:  F Tagliavini; C Pellegrini; F Sardone; S Squarzoni; M Paulsson; R Wagener; F Gualandi; C Trabanelli; A Ferlini; L Merlini; S Santi; N M Maraldi; C Faldini; P Sabatelli
Journal:  Biochim Biophys Acta       Date:  2014-06-05

7.  Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.

Authors:  Luciano Merlini; Alessandro Vagheggini; Daniela Cocchi
Journal:  Front Aging Neurosci       Date:  2014-10-07       Impact factor: 5.750

8.  Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.

Authors:  Francesca Gualandi; Elisa Manzati; Patrizia Sabatelli; Chiara Passarelli; Matteo Bovolenta; Camilla Pellegrini; Daniela Perrone; Stefano Squarzoni; Elena Pegoraro; Paolo Bonaldo; Alessandra Ferlini
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

9.  Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

Authors:  Maria Teresa Miscione; Francesca Bruno; Claudio Ripamonti; Giuliana Nervuti; Riccardo Orsini; Cesare Faldini; Massimo Pellegrini; Daniela Cocchi; Luciano Merlini
Journal:  ScientificWorldJournal       Date:  2013-09-12

10.  Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.

Authors:  E Sorato; S Menazza; A Zulian; P Sabatelli; F Gualandi; L Merlini; P Bonaldo; M Canton; P Bernardi; F Di Lisa
Journal:  Free Radic Biol Med       Date:  2014-07-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.